Last edition
News about "Mabwell Malaysia expansion"
Mabwell Signs Malaysia Deal for Denosumab Biosimilars
Mabwell signs a Malaysia licensing deal for denosumab biosimilars, with its partner leading registration and commercialisation while Mabwell handles development, production and supply, strengthening its Asia market expansion strategy.
Mabwell Malaysia Expansion | 20/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members